Valacyclovir hydroc
Ended Awarded Last action
- Contract number
- SPE2DP25F125L
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$1,310 | |
| Original award | $1,310 |
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,310.07 for Valacyclovir Hydrochloride on September 17, 2025, with an ultimate completion date of September 29, 2025. This delivery order was issued without a set-aside designation and is funded by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-oriented federal agency. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million and valid through November 2026, which enables the procurement of a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities nationwide.
Valacyclovir Hydrochloride is an antiviral medication commonly used to treat herpes virus infections. As a pharmaceutical wholesaler specializing in both branded and generic prescription drugs, biologics, and medical consumables, DMS Pharmaceutical Group leverages its established position within the federal pharmaceutical supply chain to fulfill discrete delivery orders for specific medications as required by military health facilities. The company's robust contract history with the DLA and its status as a woman-owned small business demonstrate its capability to compete effectively in federal procurement markets while maintaining consistent supplier relationships for critical pharmaceutical products.
Quick answers
Who was awarded contract SPE2DP25F125L?
SPE2DP25F125L was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 17, 2025.
How much is contract SPE2DP25F125L worth?
The government has obligated $0 on SPE2DP25F125L.
Is contract SPE2DP25F125L an order under another contract?
Yes. SPE2DP25F125L is a delivery order under SPE2DX15D9383, an indefinite delivery contract.
Was contract SPE2DP25F125L competed?
The extent of competition for SPE2DP25F125L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award